VALENS GROWORKS COMPANY PROFILE CSE ticker: VGW
VALENS GROWORKS A multi-licensed, vertically integrated provider of cannabis products and services with a focus on proprietary extraction processes. We bring pure, high quality cannabis products, manufacturing services and expertise to medical, recreational, and international markets, while advancing the industry through research and analysis. 2
THE VALENS ADVANTAGE THE WORLD IS OUR MARKET Health Canada Dealer s License (multiple), ACMPR Cultivation License pending, EU GMP certifcation pending, Hemp License pending, Nutraceutical License pending setting Valens up for every servicing and consumer product opportunity, globally. SEED TO SALE TRANSPARENCY AND CONTROL Different strains, compounds and growing techniques provide different desired effects in finished products. By controlling our supply from the source right through to processing, we re able to ensure our products qualities are maximized and always purpose-driven. DEVELOPMENT Through one of our Dealer s Licenses we hold the ability to perform research and clinical trials to better understand Cannabis and it s benefits, and to lead the way in purposeful product offerings around PROPRIETARY PROCESSING Our processing methods have been customized to ensure that the end product does not lose the valuable complexity of compounds resposible for the spectrum of desired effects that are often lost in the refining process. BIG PICTURE BRANDING The Valens brand is recognized for delivering the most science driven, responsibly tested, sustainably derived products and services in the market. PRODUCT FLEXIBILITY We have the ability to produce a wide variety of products, allowing Valens to capitalize on multiple markets from medical to recreational to preferential method of consumption. INDUSTRY-BACKED The experience and reputation of the team at Valens speaks for itself. We are a preferred partner of Canopy and other large and/or reputable industry players. 3
ELEVATING THE SECTOR Processes & Purity Proprietary distilling process ensures versatile, full-spectrum oils & extracts Exceptionally pure product production Free from additives & adjuncts Standards & Trust ISO 17025 Accredited first ever in Canada for testing of cannabis Exceeds highest standards for Quality Assurance (EU GMP pending) Ensures consumers are safe and consistent for customers Consumers know our brands and our partners can be trusted Industry Know-How Proven leadership professionals CEO with 17 years grassroots experience Accredited and respected scientific professionals Support and validation from $80B company, Thermo Fisher Scientific 4
OUR SUBSIDIARIES VALENS AGRITECH LTD. World-class, high capacity cannabis extraction and R&D facility VALENS FARMS State of the art, purpose-built, 400,000 square foot greenhouse cultivation facility (in development). SUPRA THC SERVICES INC. Full service, ISO 17025 accredited, testing laboratory named the Center of Excellence for Plant-Based Science by Thermo Fischer Scientific 5
OUR SUBSIDIARIES: VALENS AGRITECH LTD. Health Canada Dealers Licensed cannabis extraction center Extraction center with cultivation and research capabilities Proprietary, customized cannabis extraction processes Ability to import and export wholesale cannabis products world-wide Third party cannabis product development Unique cannabis strain genetics 25,000 sq ft plant to facilitate additional extraction production EU GMP Certification pending for global export anywhere Late stage ACMPR LP applicant 6
OUR SUBSIDIARIES: VALENS FARMS A 50/50 joint venture state-of-the-art development with Kosha Projects: 400,000 sq ft, purpose-built, cannabis cultivation facility in the heart of B.C. s Okanagan Valley Growing specific strains of cannabis through monocropping methodology specifically for extraction Faster growing times by monocropping means more crop turnover annually and less labour required Valens practice of monocropping means we deliver the highest quality cannabis plant possible. Flower production to be extracted by Valens Agritech and primarily made into Valens branded product 7
OUR SUBSIDIARIES: SUPRA THC SERVICES INC. Health Canada Dealers Licensed for testing and analysis Leading edge research laboratory Service provider specializing in the testing of metals, residual solvents, pesticides, mold, terpenes and cannabinoid profile ISO 17025 accreditation, first lab to be accredited in Canada for a cannabis matrix Named a Center of Excellence in plant-based science by $80B medical instruments company Thermo Fischer Scientific Setting the domestic standard in Health Canada-required third party product verification as well as globally. 8
REVENUE STREAMS EXTRACTION IS THE FOUNDATION OF OPPORTUNITY Cannabis Oil: Used in an array of products using desired compounds found in cannabis such as CBD, THC, terpenes and more. EDIBLES Snack edibles Trail mix, protein bars, jerky, sweets, etc. Infused prepared meals Food additives Cooking oils, honey, peanut butter Just add cannabis beverage containers with cannabis oil preloaded in the top, just like the vitamin waters with the powder dispenser on top Drinks alcoholic or non-alcoholic Oral sprays FLOWER High THC/CBD bud V-Pucks, dose control Pre-rolled joints Accessories (eg. rolling papers) OIL/TINCTURES High THC/CBD tinctures Vaporizer Cartridges and Pens Capsules Concentrates TOPICALS Balms/creams/salves Bath soaks/salts Skin care products Body sprays Lubricants Essential oils Sublingual patches Transdermal patches 9
REVENUE STREAMS RESIN Processing from flower to crude oil Fee for service EXTRACTION REFINED OIL Processing from flower to oil ready for market Revenue share or fee for service WHITE LABEL PRODUCTS Processing and packaging of oil ready for market Revenue Share LAB TESTING SERVICES DIRECT SALES EXPORT SALES 3RD PARTY RESEARCH & DEVELOPMENT License allows development, testing and refining of derivative products that fall outside of the ACMPR PRODUCT DEVELOPMENT R&D for some of the largest cannabis and health companies Ability to start production now of anticipated future approved products 10
OUR INTERNATIONAL REACH: EXPORT OPPORTUNITIES WITH DEALERS LICENSE GLOBAL MARKET GLOBAL LEGAL MARIJUANA MARKET EXPECTED TO REACH 146.4 BILLION USD BY 2025 -Report Buyer, April 2018 EUROPEAN MEDICAL AND RECRECATIONAL MARKETS EXPECTED TO GROW TO 116.4 BILLION BY 2028 - The European Cannabis Report, Prohibition Partners AS OF JUNE 7, 2018, CANADA IS THE FIRST MEMBER OF THE G7 TO LEGALIZE CANNABIS FOR RECREATIONAL USE ACROSS THE COUNTRY CANADA -Rx 2001 RECREATIONAL - 2018 GERMANY-Rx 2017 MALTA -Rx 2018 JAMAICA -Rx 2017 COLUMBIA -Rx 2017 AUSTRALIA -Rx 2017 NEW ZEALAND -Rx 2017 IN NEGOTIATIONS WITH THE ABOVE MARKETS TO STRUCTURE PARTNERSHIPS AND DISTRIBUTION NETWORKS 11
OUR PARTNERS Kosha Projects Inc. 12
MILESTONES ACHIEVED Last $5M financing over-subscribed by $7.5M for a total of $12.5M; raised for the purposes of development and operations 1st extraction: Successful extraction of 100 kg of 100% cannabis oil used for research and development 1st harvest: Successful harvest of cannabis at Kelowna facility with THC content above industry standard Increased extraction capacity by 600% Kelowna facility expansion complete to 25,000 sq ft with new office, extraction and processing space Development has begun with Kosha Projects on Valens Farms to build 400,000 sq ft greenhouse in B.C. s Okanagan Valley Partnership agreement signed with SpeakEasy Growers to provide GMP-grade product, international development opportunities and more Letter of intent with Colombia-based company Eticann to supply Valens with steady stream of quality flower not otherwise found in Canada 13
FUTURE MILESTONES 2018 4 TH QUARTER Begin sales of recreational cannabis products Commence medical sales to international markets GMP certification Launch of Valens-branded products line Receipt of pending LP license to cultivate 2019 1 ST QUARTER 2 ND QUARTER 3 RD QUARTER 4 TH QUARTER First planting in Valens Farms (Phase 1) First harvest in Valens Farms (Phase 1) First planting of Phase 1B at Valens Farms First harvest of Phase 1B at Valens Farms Expansion of extraction capabilities at VAL 14 X
OUR TEAM TYLER ROBSON CEO / DIRECTOR With 15+ years grassroots experience, Mr. Robson was Chief Operating Officer of the Company until taking the reins as Chief Executive Officer in May 2017, as well as remaining Director of Operations at Valens AgriTech Inc. CHRIS BUYSEN, MPAcc, CPA, CA CFO Mr. Buysen has over 15 years of diverse financial experience working as a senior financial executive with many public and private organizations in a wide range of industries including retail, pharmacy and consumer packaged goods. CHANTEL POPOFF VICE PRESIDENT In 2007, Ms. Popoff was appointed Director of Operations, then Director of Marketing for a fast-growing Western Canadian retail pharmacy chain. In 2013 she joined a natural health food company as Director of Marketing and was promoted to President in 2016. SCOTT YOUNG INVESTOR RELATIONS & BUSINESS DEVELOPMENT Mr. Young s focus at Valens is corporate finance initiatives. Mr. Young has spent the past 15 years working in the capital market sectors of Canada, the United States and Europe. QUINN SHISKIN HEAD OF EXTRACTION AND PRODUCTION Mr. Shiskin s career emanates around production as a multi-ticketed Red Seal tradesman; where he worked in a variety of industries including mining, oil sands, LNG, pulp and paper, and in the construction industry. With these skills, he entered the extraction industry where he revolutionized the process along the way. JOHN W. CONROY, QC ADVISOR Mr. John Conroy has extensive background as legal counsel in constitutional, administrative and criminal law cases with respect to cannabis legislation, and acted as lead counsel in several ground-breaking legal proceedings. 15
PEER EVALUATION MARKET CAP $105M $494M $256M $213M $123M CURRENT PRODUCTION 6,000 Approx 14,500 217,000 4,000 CAPACITY (KG) 50,000 NEAR TERM PRODUCTION 400,000-150,000 635,000 100,000 + INCREASE (SQ FT) 300,000 HIGH CAPACITY EXTRACTION Y N N N N IN HOUSE EU GMP PENDING N N N N CERTIFICATION 16
OUR SUMMARY Valens GroWorks ("VGW") owns 100% of Valens Agritech, Supra THC and Valens Farms corp. VGW currently has 2 Dealers Licenses with the ability to cultivate, research, test, store, sell, export and import. LP license approval imminent. When VGW receives its LP it will be the one of only 8 Cannabis companies in Canada to have both Health Canada licenses. Extraction facility is built (GMP certification pending). Extraction services of cannabis is currently underway through VGW's Dealers License. Construction of Valens Farms is underway, providing 400,000 sq ft of state-of-the-art, purpose built cultivation capacity specifically for extracted goods VGW is currently in negotiations with a number of companies internationally to develop and produce Cannabis related products, edibles, sprays, nutrients, lights and vaporizers Supra THC is the only cannabis laboratory in the world to receive the Thermo Fisher "Center of Excellence in Plant Based Medicines" and is the first in Canada to be accredited with the highest globally-recognized compliance standards for cannabis 17
SCOTT YOUNG BUSINESS DEVELOPMENT & INVESTOR RELATIONS SCOTT@VALENSGROWORKS.COM (705) 888-2756 VALENSGROWORKS.COM 130 ADELAIDE ST. W, OXFORD TOWER, SUITE 3002 TORONTO, ON, M5H 3P5 18